Practical diagnostic utility of thyroid fine-needle aspiration cell blocks: is always too much?

Jacob Edens1, Momal Chand1, Ishaq Asghar1

  • 1Ascension St. John Hospital, Detroit, Michigan.

Insights

Cell blocks (CB) rarely aid thyroid fine-needle aspiration (tFNA) diagnoses and significantly increase turnaround time (TAT). Producing cell blocks only when needed can improve efficiency for thyroid nodule assessment.

Area of Science:

  • Pathology
  • Cytopathology
  • Endocrinology

Background:

  • Thyroid fine-needle aspiration (tFNA) is a primary method for evaluating thyroid nodules.
  • Morphologic assessment of tFNA smears is generally accurate, but cell blocks (CB) can be used for ancillary studies like immunohistochemistry (IHC).
  • Accurate and efficient cytologic diagnoses are crucial for guiding clinical decisions in thyroid nodule management.

Purpose of the Study:

  • To evaluate the diagnostic utility of cell blocks (CB) in the assessment of thyroid fine-needle aspiration (tFNA) specimens.
  • To determine the impact of CB preparation on the turnaround time (TAT) of tFNA diagnoses.
  • To assess the contribution of CB to the final diagnosis and the need for ancillary studies.

Main Methods:

  • Retrospective chart review of tFNA specimens from January 2014 to July 2019.
  • Data collected included turnaround time (TAT), diagnosis, CB preparation, and diagnostic contribution of CB.
  • Statistical analysis included descriptive statistics, the chi-squared test, and the Mann-Whitney U-test.

Main Results:

  • Of 2321 tFNA specimens, 40.2% included a CB, but only 0.3% were diagnostically contributory.
  • The median TAT for specimens with a CB was 1 day, compared to 0 days for those without a CB, representing a significant increase (P < 0.0001).
  • Cases with CBs were significantly more likely to have a TAT greater than 1 day (65%) or 3 days (25.4%) compared to cases without CBs.

Conclusions:

  • The diagnostic utility of cell blocks in tFNA for thyroid nodules is very low.
  • The addition of a CB significantly increases turnaround time, delaying patient results.
  • Producing CBs only when needed (e.g., for ambiguous smears or ancillary tests) can reduce TAT and resource utilization.
Abstract

Related Concept Videos